跳至主要内容
临床试验/ISRCTN11211024
ISRCTN11211024已完成未知

Carer administration of as-needed subcutaneous medication for breakthrough symptoms in home-based dying patients: a UK study (CARIAD)

Bangor University0 个研究点目标入组 40 人开始时间: 2016年9月27日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30732624 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32484432/ (added 28/10/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Dyads of dying patients and their home-based carers
  • 2. Adult patients in the last weeks of life
  • 3. Who are likely to use the oral route for medication
  • 4. Have expressed a preference to die at home
  • 5. Have a family carer who is over 18
  • 6. Carer is willing to have this extended role
  • 7. Carer is willing to have subcutaneous injection training

排除标准

  • 1. Patient or carer is under 18
  • 2. Patient or carer not willing to entertain concept of lay carer administering subcutaneous medication
  • 3. Patient or carer has a known history of substance abuse
  • 4. Patient has had previous known adverse reactions to substance meds
  • 5. Clinician judges that risk assessment criteria are not met for a dyad

研究者

相似试验